Aspirin Is Being Investigated as a Possible Treatment for COVID-19News
Aspirin will be investigated in the world’s largest clinical trial of treatments for patients hospitalized with COVID-19 – the Randomised Evaluation of COVid-19 thERapY (RECOVERY) trial.Read more
Interim Analysis Suggests SARS-CoV-2 Vaccine Has 90% Efficacy RateNews
Pharmaceutical company Pfizer and biotechnology company BioNTech have announced the first interim efficacy data from a large-scale trial evaluating BNT162b2, a vaccine candidate developed against SARS-CoV-2. Their press release indicates a vaccine efficacy rate of ~90% seven days after a second dose of the vaccine is administered, however the data is yet to be published.Read more
Method Identifies Llama Nanobodies With "Ultra-High" SARS-CoV-2 Neutralization PotencyNews
In Science, researchers at the University of Pittsburgh School of Medicine describe a new method to extract tiny but extremely powerful SARS-CoV-2 antibody fragments from llamas, which could be fashioned into inhalable therapeutics with the potential to prevent and treat COVID-19.
Gene That Controls Food Cravings and Desire to Exercise in Mice IdentifiedNews
National Institutes of Health researchers have discovered a gene in mice that controls the craving for fatty and sugary foods and the desire to exercise.Read more